Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Sterling, Richard K., Lissen, Eduardo, Clumeck, Nathan, Sola, Ricard, Correa, Mendes Cassia, Montaner, Julio, S. Sulkowski, Mark, Torriani, Francesca J., Dieterich, Doug T., Thomas, David L., Messinger, Diethelm, Nelson, Mark·2006·Hepatology
DOI 10.1002/hep.21178

Cited by (1,007)

Items 601–700 of 1,007

  1. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD
    Stergios A. Pοlyzos, Nikolaos Perakakis, Chrysoula Boutari, Jannis Kountouras, Wael Ghaly, Athanasios D. Anastasilakis, Asterios I. Karagiannis, Christos Socrates Mantzoros · 2019 · The Journal of Clinical Endocrinology & Metabolism
  2. Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population
    Yoshitaka Ando, Mirai Yamazaki, Hiroya Yamada, Eiji Munetsuna, Ryosuke Fujii, Genki Mizuno, Naohiro Ichino, Keisuke Osakabe, Keiko Sugimoto, Hiroaki Ishikawa et al. · 2019 · Scientific Reports
  3. Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease
    José Altamirano, Qiaochu Qi, Sabina Choudhry, Mohamed Abdallah, Ashwani Kumar Singal, Abhinav Humar, Ramon A. Bataller, Amir Ali Borhani, Andrés Duarte‐Rojo · 2020 · Translational Gastroenterology and Hepatology
  4. Impact of the Fibrosis-4 Index on Risk Stratification of Cardiovascular Events and Mortality in Patients with Atrial Fibrillation: Findings from a Japanese Multicenter Registry
    Yuki Saito, Yasuo Okumura, Koichi Nagashima, Daisuke Fukamachi, Katsuaki Yokoyama, Naoya Matsumoto, Eizo Tachibana, Keiichiro Kuronuma, Koji Oiwa, Michiaki Matsumoto et al. · 2020 · Journal of Clinical Medicine
  5. Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
    Rommel Zambrano-Huailla, Laura Vilar Guedes, José Tadeu Stefano, Arthur Alencar Arrais de Souza, Sebastián Marciano, Erika Yuki Yvamoto, Matheus Truccolo Michalczuk, Denise Siqueira Vanni, Hernan Rodriguez, Flair José Carrilho et al. · 2020 · Annals of Hepatology
  6. Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?
    Johanna Heitmann, Verena Gerlinde Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan · 2021 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
  7. Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects
    Alexandra Feldman, Bernhard Wernly, Georg Strebinger, Sebastian K. Eder, Stephan Zandanell, David Niederseer, Michael Straßer, Heike Haufe, Karl Sotlar, Bernhard Paulweber et al. · 2021 · Journal of Gastrointestinal and Liver Diseases
  8. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
    Yinlian Wu, Rahul Kumar, Ming-Fang Wang, Medha Singh, Jiaofeng Huang, Yueyong Zhu, Su Lin · 2021 · World Journal of Gastroenterology
  9. The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients
    Sahar Hossam El-Hini, Engy A. Wahsh, Ahmed Abdullah Elberry, Nadia Farouk El Ameen, Ahmed Abdel Fadil Saedii, Shereen Mahmoud Refaie, Asmaa A. Elsayed, Hoda Rabea · 2022 · Pharmaceuticals
  10. Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study
    Fa-Juan Rui, Y. Yeo, Liang Xu, Qi Zheng, Xiaoming Xu, Wen-Jing Ni, Youwen Tan, Qing-Lei Zeng, Zebao He, Xiaorong Tian et al. · 2024 · EClinicalMedicine
  11. Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score
    Pimsiri Sripongpun, Apichat Kaewdech, Prowpanga Udompap, W. Ray Kim · 2024 · JHEP Reports
  12. Impact of serumWisteria floribundaagglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis
    Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Takashi Nishimura, Kazunori Yoh, Nobuhiro Aizawa, Yoshiyuki Sakai et al. · 2015 · Hepatology Research
  13. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients
    The ANRS CO HEPAVIH Cohort · 2015 · AIDS
  14. Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein for patients with chronic hepatitis B and C: a comparative study
    Hiroki Nishikawa, Hirayuki Enomoto, Y Iwata, Kyohei Kishino, Yoshihiro Shimono, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Takashi Nishimura, Kosei Yoh et al. · 2016 · Journal of Viral Hepatitis
  15. Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
    Chih‐Chien Yao, Chao‐Hung Hung, Tsung‐Hui Hu, Sheng‐Nan Lu, Jing-Hung Wang, Chung-Mo Lee, Chien‐Hung Chen · 2017 · Scientific Reports
  16. Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection
    Satoru Joshita, Yuki Ichikawa, Takeji Umemura, Yoko Usami, Ayumi Sugiura, Soichiro Shibata, Tomoo Yamazaki, Naoyuki Fujimori, Michiharu Komatsu, Akihiro Matsumoto et al. · 2017 · Hepatology Research
  17. Restoring Inflammatory Mediator Balance after Sofosbuvir-Induced Viral Clearance in Patients with Chronic Hepatitis C
    Geórgia do Nascimento Saraiva, Natalia Fonseca do Rosário, Thalia Medeiros, Paulo Emílio Corrêa Leite, Gilmar S. Lacerda, Thaís Guaraná de Andrade, Elzinandes Leal de Azeredo, Petronela Ancuța, Jorge Reis Almeida, Analúcia Rampazzo Xavier et al. · 2018 · Mediators of Inflammation
  18. Liver elasticity in healthy individuals by two novel shear-wave elastography systems—Comparison by age, gender, BMI and number of measurements
    Anesa Mulabecirovic, Anders Batman Mjelle, Odd Helge Gilja, Mette Nåmdal Vesterhus, Roald Flesland Havre · 2018 · PLoS ONE
  19. The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases
    Eda Kaya, Alev Bakır, Fatih Eren, Yusuf Nadir Yilmaz · 2020 · Hepatology forum/Hepatology forum (Online)
  20. The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
    Maurizio Soresi, Daniela Cabibi, Rosaria Vincenza Giglio, Stefania Martorana, Giuseppina Guercio, Rossana Porcasi, Antonino Terranova, Luigi Antonio Lazzaro, Maria Rita Emma, Giuseppa Augello et al. · 2020 · BioMed Research International
  21. Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
    Kenichiro Murayama, Michiaki Okada, Kenichi Tanaka, Chika Inadomi, Wataru Yoshioka, Yoshihito Kubotsu, Tomomi Yada, Hiroshi Isoda, Takuya Kuwashiro, Satoshi Oeda et al. · 2021 · Diagnostics
  22. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
    Saleh A. Alqahtani, Pegah Golabi, James M. Paik, Brian P Lam, Amir H. Moazzez, Hazem A. Elariny, Zachary D Goodman, Zobair M. Younossi · 2021 · Obesity Surgery
  23. Systematic Review and Meta–Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection
    Abdel Aziz Shaheen, Robert P. Myers · 2008 · HIV Clinical Trials
  24. APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection
    Sumit Rungta, Shweta Kumari, Amar Deep, Kamlendra Verma, Suchit Swaroop · 2021 · Journal of Family Medicine and Primary Care
  25. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
    Rita Basu, Mazen Noureddin, Jeanne M. Clark · 2022 · Mayo Clinic Proceedings
  26. Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease
    A‐Na Liu, Cuifang Xu, Ya‐Ru Liu, Dan‐Qin Sun, Ling Jiang, Liang‐Jie Tang, Pei‐Wu Zhu, Sui‐Dan Chen, Wen‐Yue Liu, Xiao‐Dong Wang et al. · 2023 · Alimentary Pharmacology & Therapeutics
  27. AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension
    Richard K. Sterling, Sumeet K. Asrani, Deborah Levine, Andrés Duarte‐Rojo, Keyur Patel, Maria Isabel Fiel, Daniel H. Leung, Bachir A. Taouli, Mouaz Alsawas, Mohammad Hassan Murad et al. · 2024 · Hepatology
  28. Similar Progression of Fibrosis Between HIV/HCV–Infected and HCV–Infected Patients: Analysis of Paired Liver Biopsy Samples
    Richard K. Sterling, Jacob A. Wegelin, Paula G. Smith, R. Todd Stravitz, Velimir A. Luketic, Michael A. Fuchs, Puneet Puri, Mitchell L. Shiffman, Melissa J. Contos, A. Scott Mills et al. · 2010 · Clinical Gastroenterology and Hepatology
  29. Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease
    Cemal Firat Subaşi, Umut Emre Aykut, Yusuf Nadir Yilmaz · 2014 · European Journal of Gastroenterology & Hepatology
  30. Noninvasive Tools to Assess Hepatic Fibrosis: Ready for Prime Time?
    Paul A. Schmeltzer, Jayant A. Talwalkar · 2011 · Gastroenterology Clinics of North America
  31. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection
    Paolo Sacchi, Serena Cima, Marta Corbella, Giuditta Comolli, Antonella Chiesa, Fausto Baldanti, Catherine Klersy, Stefano Novati, Patrizia Mulatto, Mara Mariconti et al. · 2014 · Digestive and Liver Disease
  32. Are non‐invasive fibrosis markers for chronic hepatitis B reliable in sub‐Saharan Africa?
    Hailemichael Desalegn, Hanna Aberra, Nega Berhe, Svein Gunnar Gundersen, Asgeir Johannessen · 2017 · Liver International
  33. Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease
    Ahmed M. Gharib, Ma Ai Thanda Han, Eric G. Meissner, David Erwin Kleiner, Xiongce Zhao, Mary E. McLaughlin, Lindsay Matthews, Bisharah Rizvi, Khaled Z. Abd‐Elmoniem, Ralph Sinkus et al. · 2017 · BioMed Research International
  34. Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients
    Minhui Dong, Jingwen Wu, Xueping Yu, Jing Li, Sisi Yang, Xun Qi, Richeng Mao, Yongmei Zhang, Jie Yu, Haoxiang Zhu et al. · 2018 · Liver International
  35. Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study
    Yumin Xu, Yuhan Liu, Zhujun Cao, Lin Wang, Ziqiang Li, Zi-Ke Sheng, Wei Cai, Hui Wang, Shisan Bao, Qing Xie · 2019 · Digestive and Liver Disease
  36. A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease
    Joeri Lambrecht, Stefaan Verhulst, Inge Mannaerts, Jan‐Peter Sowa, Jan Best, Ali E. Canbay, Hendrik Reynaert, Leo A. van Grunsven · 2019 · EBioMedicine
  37. Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease
    Jadine H. Scragg, Leah Avery, Sophie Cassidy, Guy Taylor, Laura Haigh, Marie Boyle, Michael I. Trenell, Quentin Mark Anstee, Stuart McPherson, Kate Hallsworth · 2020 · Clinical and Translational Gastroenterology
  38. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co‐infection
    Roberto José de Carvalho‐Filho, Leonardo de Lucca Schiavon, Janaína Luz Narciso-Schiavon, Juliana P. Sampaio, Valéria Pereira Lanzoni, Maria Lúcia Gomes Ferraz, Antônio Eduardo Benedito Silva · 2008 · Liver International
  39. Endoscopic sleeve gastroplasty — minimally invasive treatment for non-alcoholic fatty liver disease and obesity
    Jagtap, Nitin, Kalapala, Rakesh, Katakwar, Abhishek, Sharma, Mithun, Aslam, Mohsin, Gupta, Rajesh, Rao, P Nagaraja, Goud, Rajesh, Tandan, Manu, Kanakagiri, Haranath et al. · 2021 · Indian Journal of Gastroenterology
  40. Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes
    Xiaodan Zhang, Yimei Chen, Huiyu Ye, Zirui Luo, Jiahong Li, Zhishan Chen, Enting Zhang, Wangen Li · 2022 · Endocrine
  41. Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa
    Asgeir Johannessen, Alexander J. Stockdale, Marc Henrion, Edith Nonyelum Okeke, Moussa Seydi, Gilles Wandeler, Mark Wayne Sonderup, C Wendy Spearman, Michael J. Vinikoor, Edford Sinkala et al. · 2023 · Nature Communications
  42. Elevated C-reactive protein mediates the liver-brain axis: a preliminary study
    Jiang, Rongtao, Wu, Jing, Rosenblatt, Matthew, Dai, Wei, Rodriguez, Raimundo X., Sui, Jing, Qi, Shile, Liang, Qinghao, Xu, Bin, Meng, Qinghua et al. · 2023 · eBioMedicine
  43. Liver integrity and the risk of Alzheimer's disease and related dementias
    Yifei Lü, James Russell Pike, Ron Cornelis Hoogeveen, Keenan A. Walker, Laura M. Raffield, Elizabeth Selvin, Christy L. Avery, Stephanie Mulherin Engel, Michelle M. Mielke, Tanya Garcia et al. · 2023 · Alzheimer s & Dementia
  44. Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C
    Jérôme Boursier, Charlène Brochard, Sandrine Bertrais, S. Michalak, Yves Gallois, Isabelle Fouchard‐Hubert, F. Oberti, Marie‐Christine Rousselet, Paul Calès · 2014 · Alimentary Pharmacology & Therapeutics
  45. Clinical implications of serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein in treatment‐naïve chronic hepatitis B
    Akio Ishii, Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Kyohei Kishino, Yoshihiro Shimono, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Takashi Nishimura et al. · 2016 · Hepatology Research
  46. A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis
    Xavier Verhelst, Dieter Vanderschaeghe, Laurent Castéra, Tom Raes, Anja M. Geerts, Claire Francoz, Roos Colman, François Durand, Nico Callewaert, Hans Van Vlierberghe · 2016 · Clinical Cancer Research
  47. Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis
    Joeri Lambrecht, Pieter Jan Poortmans, Stefaan Verhulst, Hendrik Reynaert, Inge Mannaerts, Leo A. van Grunsven · 2017 · Frontiers in Pharmacology
  48. FIB‐4 stage of liver fibrosis predicts incident heart failure among HIV‐infected and uninfected patients
    Kaku So‐Armah, Joseph K. Lim, Vincent Lo Re, Janet P. Tate, Chung‐Chou H. Chang, Adeel Ajwad Butt, Cynthia L. Gibert, David Rimland, Vincent C. Marconi, Matthew Bidwell Goetz et al. · 2017 · Hepatology
  49. High hepatitis C cure rates among black and nonblack human immunodeficiency virus–infected adults in an urban center
    Oluwaseun O Falade-Nwulia, Catherine Gayle Sutcliffe, Juhi Moon, Geetanjali Chander, Tanyaporn Wansom, Jeanne C. Keruly, Jennifer Katzianer, Amy Nathanson, Jillian Marks, Shruti H. Mehta et al. · 2017 · Hepatology
  50. Association between sarcopenia and osteoporosis in chronic liver disease
    Manabu Hayashi, Kazumichi Abe, Masashi Fujita, Ken Okai, Atsushi Takahashi, Hiromasa Ohira · 2018 · Hepatology Research
  51. CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus
    Meghan G. Lubner, Daniel Jones, John D. Kloke, Adnan Said, Perry Joseph Pickhardt · 2018 · British Journal of Radiology
  52. Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals
    Edoardo Giovanni Giannini, Mattia Crespi, Mariagiulia Demarzo, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Francesco Torre, Patrizia Zentilin, Vincenzo Savarino · 2018 · European Journal of Clinical Investigation
  53. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma
    Felipe B. Maegawa, Lauren Shehorn, Hassan Aziz, John B. Kettelle, Tun Jie, Taylor Sohn Riall · 2019 · JAMA Network Open
  54. Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population
    Kailash Kolhe, Anjali Deepak Amarapurkar, Pathik M. Parikh, Alisha Chaubal, Shamshersingh Gajendra Chauhan, Harshad B. Khairnar, Swapnil Sahebrao Walke, Meghraj Ingle, Vikas R. Pandey, Akash Shukla · 2019 · BMJ Open Gastroenterology
  55. Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co‐infected Adults
    Richard K. Sterling, Wendy C. King, Abdus S. Wahed, David Erwin Kleiner, Mandana Khalili, Mark Sulkowski, Raymond T. Chung, Mamta K. Jain, Mauricio Lisker‐Melman, David Wong et al. · 2019 · Hepatology
  56. Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring
    Carine A. Halaby, Sarah P. Young, Stephanie L. Austin, Ela Stefanescu, Deeksha Sarihyan Bali, Lani Kai Clinton, Brian P. Smith, Surekha Pendyal, Jariya Upadia, Gary R. Schooler et al. · 2019 · Genetics in Medicine
  57. FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C
    Kaku So‐Armah, Joseph K. Lim, Vincent Lo Re, Janet P. Tate, Chung‐Chou H. Chang, Adeel Ajwad Butt, Cynthia L. Gibert, David Rimland, Vincent C. Marconi, Matthew Bidwell Goetz et al. · 2020 · Progress in Cardiovascular Diseases
  58. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy
    Anna Suk-Fong Lok, Robert Perrillo, Christina M. Lalama, Michael W. Fried, Steven H. Belle, Marc G. Ghany, Mandana Khalili, Robert J. Fontana, Richard K. Sterling, Norah A. Terrault et al. · 2020 · Hepatology
  59. Impact of predictive value of Fibrosis-4 index in patients hospitalized for acute heart failure
    Naoki Shibata, Toru Kondo, S. Kazama, Yuki Kimura, Hideo Oishi, Yoshihito Arao, Hiroo Kato, Shogo Yamaguchi, Tasuku Kuwayama, Hiroaki Hiraiwa et al. · 2020 · International Journal of Cardiology
  60. Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver disease
    Satoshi Shinozaki, Toshiyuki Tahara, Alan Kawarai Lefor, Masahito Ogura · 2020 · Clinical and Experimental Hepatology
  61. Case-finding strategies in non-alcoholic fatty liver disease
    Jérôme Boursier, Emmanuel A. Tsochatzis · 2020 · JHEP Reports
  62. Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus
    Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Koji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi et al. · 2020 · Clinical Infectious Diseases
  63. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population
    Joana Rigor, Andreia Cinara Branco Diegues, José Presa, Pedro Barata, Daniela Martins‐Mendes · 2022 · Postgraduate Medicine
  64. Assessing liver fibrosis
    Laurent Castéra · 2008 · Expert Review of Gastroenterology & Hepatology
  65. Metabolic Dysfunction-associated Steatotic Liver Disease and Type 2 Diabetes: A Deadly Synergy
    Damien Leith, YeunYi Lin, Paul Brennan · 2024 · touchREVIEWS in Endocrinology
  66. Comparison of Long‐Term Clinical Outcomes Between Spontaneous and Therapy‐Induced HBsAg Seroclearance
    Jonggi Choi, Sun Hong Yoo, Young‐Suk Lim · 2020 · Hepatology
  67. Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters
    Yasunori Nagayama, Yuki Kato, T Inoue, Takeshi Nakaura, Seitaro Oda, Masafumi Kidoh, Osamu Ikeda, Toshinori Hirai · 2021 · European Radiology
  68. High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes
    Haruka Saito, Hayato Tanabe, Akihiro Kudo, Noritaka Machii, Moritake Higa, Satoshi Yamaguchi, Gulinu Maimaituxun, Kazumichi Abe, Atsushi Takahashi, Kenichi Tanaka et al. · 2021 · Scientific Reports
  69. Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort
    Nadim Mahmud, Sara E. Chapin, David Seth Goldberg, K. Rajender Reddy, Tamar Hamosh Taddei, David Edward Kaplan · 2022 · Journal of Hepatology
  70. Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
    Alfredo Caturano, Raffaele Galiero, Giuseppe Loffredo, Erica Vetrano, Giulia Medicamento, Carlo Acierno, Luca Rinaldi, Aldo Marrone, Teresa Salvatore, Marcellino Monda et al. · 2023 · Biomedicines
  71. Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999–2008
    Lihua Guan, Lei Li, Yutong Zou, Jian Zhong, Ling Qiu · 2023 · Frontiers in Cardiovascular Medicine
  72. Suboptimal performance of simple noninvasive tests for advanced fibrosis in C hinese patients with nonalcoholic fatty liver disease
    Yun Xun, Jian‐Gao Fan, Guo Qing Zang, Hong Liu, Yan Jiang, Jing Xiang, Qian Huang, Junping Shi · 2012 · Journal of Digestive Diseases
  73. Can We Predict the Degree of Fibrosis in Chronic Hepatitis C Patients Using Routine Blood Tests in Our Daily Practice?
    Ramsey C Cheung, Sue L. Currie, Hui Shen, Edmund J. Bini, Samuel B. Ho, Bhupinderjit S. Anand, Ke‐Qin Hu, Teresa Lyn Wright, Timothy R.M. Morgan · 2008 · Journal of Clinical Gastroenterology
  74. Red cell volume distribution width‐to‐platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B
    Hye Won Lee, Wonseok Kang, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Young Nyun Park, Kwang‐Hyub Han · 2015 · Liver International
  75. Non-Invasive Prediction of Hepatic Fibrosis in Patients With Chronic HCV Based on the Routine Pre-Treatment Workup
    Marwa Khairy, M.D. HEBA N.A.H. ABDEL MENAEM ABEER A. ABDEL-RAHMAN, Maissa El Raziky, Wafaa Elakel, Naglaa Ali Zayed, Hany Khatab, Gamal Esmat · 2012 · Hepatitis Monthly
  76. Stepwise Combination of Simple Noninvasive Fibrosis Scoring Systems Increases Diagnostic Accuracy in Nonalcoholic Fatty Liver Disease
    Münevver Demir, Sonja Lang, Dirk Nierhoff, Uta Drebber, Aline Hardt, Inga Wedemeyer, Sigrid Schulte, Maria Quasdorff, Tobias Goeser, Ulrich Töx et al. · 2013 · Journal of Clinical Gastroenterology
  77. Pediatric Non-alcoholic Fatty Liver Disease
    Vikas Uppal, Sana Mansoor, Katryn N. Furuya · 2016 · Current Gastroenterology Reports
  78. Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics
    Juan Berenguer, Antonio Rivero, Inmaculada Jarrín, M.J. Núñez, María Jesús Vivancos, M. Crespo Casal, María Jesús Téllez, Peré Domingo, José Antonio Iribarren, Arturo Artero et al. · 2016 · Open Forum Infectious Diseases
  79. Differences in the impact of prognostic factors for hepatocellular carcinoma over time
    Hidenori Toyoda, Takashi Kumada, Toshifumi Tada, Tsuyoki Yama, Kazuyuki Mizuno, Yasuhiro Sone, Atsuyuki Maeda, Yuji Kaneoka, Tomoyuki Akita, Junko Tanaka · 2017 · Cancer Science
  80. Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis
    Jia-Zhen Zhang, Jingjing Cai, Yao Yu, Zhi‐Gang She, Hongliang Li · 2019 · Gene Expression
  81. Prediction of hepatic metastasis and relapse in colorectal cancers based on concordance analyses with liver fibrosis scores
    Xiang Hu, Audrey Marietta, Wei‐Xing Dai, Ya-Qi Li, Xiaoji Ma, Long Zhang, Sanjun Cai, Jun‐Jie Peng · 2020 · Clinical and Translational Medicine
  82. Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
    Tongai Gibson Maponga, Anna L. McNaughton, Marije Van Schalkwyk, Susan Hugo, Chikezie Chinedu Nwankwo, Jantjie Taljaard, Jolynne Mokaya, David A. B. Smith, Cloete van Vuuren, Dominique Goedhals et al. · 2020 · Journal of Infection
  83. The Fibrosis-4 Index Is Associated With Need for Mechanical Ventilation and 30-Day Mortality in Patients Admitted With Coronavirus Disease 2019
    Richard K. Sterling, Tavis Oakes, Tamas S. Gal, Michael P Stevens, Marjolein deWit, Arun Jayant Sanyal · 2020 · The Journal of Infectious Diseases
  84. Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR
    David Drummond, Jérémy Dana, Laureline Berteloot, Elena K. Schneider‐Futschik, F. Chedevergne, Céline Bailly-Botuha, Thao Nguyen‐Khoa, Mathieu Cornet, Muriel Le Bourgeois, Dominique Debray et al. · 2021 · Journal of Cystic Fibrosis
  85. Screening for nonalcoholic fatty liver disease-when, who and how?
    Christoph G. Dietrich, Monika Rau, Andreas Geier · 2021 · World Journal of Gastroenterology
  86. Accuracy of Simple Biochemical Tests in Identifying Liver Fibrosis in Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis C Virus
    Cristina Tural, Jordi Tor, Arantza Sanvisens, Núria Pérez‐Álvarez, Elisenda Martínez-Carbonell, Isabel Ojanguren, Javier García‐Samaniego, Juergen Kurt Rockstroh, Eva Barluenga, Roberto Muga et al. · 2008 · Clinical Gastroenterology and Hepatology
  87. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study
    I.-T. Wu, T.-H. Hu, C.-H. Hung, Shiyun Lu, J.-H. Wang, C.-M. Lee, C‐H. Chen · 2017 · Clinical Microbiology and Infection
  88. Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK Biobank participants
    Shen Chen, Juan Pang, Rong Huang, Hongliang Xue, Xu Chen · 2023 · Hepatology International
  89. High inherited risk predicts age-associated increases in fibrosis in patients with MASLD
    Luis Antonio Díaz, William Alazawi, Saaket Agrawal, Juan Pablo Arab, Marco A. Arrese, Francisco Javier Idalsoaga, Fernando Javier Barreyro, Adrian Carlos Gadano, Sebastián Marciano, Jorge Martínez Morales et al. · 2025 · Journal of Hepatology
  90. Routine blood tests to predict liver fibrosis in chronic hepatitis C
    Yung‐Yu Hsieh · 2012 · World Journal of Gastroenterology
  91. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection
    Paul Calès, Philippe Halfon, Dominique Batisse, Fabrice Carrat, Philippe Perré, Guillaume Pénaranda, Dominique Guyader, Louis d’Altéroche, Isabelle Fouchard‐Hubert, C. Michelet et al. · 2010 · Journal of Hepatology
  92. NIKEI: A New Inexpensive and Non-Invasive Scoring System to Exclude Advanced Fibrosis in Patients with NAFLD
    Münevver Demir, Sonja Lang, Martin Schlattjan, Uta Drebber, Inga Wedemeyer, Dirk Nierhoff, Ingrid Becker, Jan Sowa, Ali E. Canbay, Ulrich Töx et al. · 2013 · PLoS ONE
  93. Lower Frailty Is Associated with Successful Cognitive Aging Among Older Adults with HIV
    Lindsay M. K. Wallace, Maria Ferrara, Thomas D. Brothers, Sara Garlassi, Susan Kirkland, Olga Theou, Stefano Zona, Cristina Mussini, David J. Moore, Kenneth J. Rockwood et al. · 2016 · AIDS Research and Human Retroviruses
  94. Serum micro RNA s as predictors for liver fibrosis staging in hepatitis C virus‐associated chronic liver disease patients
    Olfat Gamil Shaker, Mahmoud Ahmed Senousy · 2017 · Journal of Viral Hepatitis
  95. Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
    Satoru Joshita, Takeji Umemura, Yoko Usami, Yūki Yamashita, Gary L. Norman, Ayumi Sugiura, Tomoo Yamazaki, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto et al. · 2018 · Scientific Reports
  96. Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy‐proven Japanese non‐alcoholic fatty liver disease patients
    Takanori Ito, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Kazuhiko Hayashi, Daisaku Nishimura, Hidenori Toyoda, Takashi Kumada, Hidemi Goto et al. · 2018 · Journal of Gastroenterology and Hepatology
  97. Vitamin E sequestration by liver fat in humans
    Pierre-Christian Violet, Ifechukwude Ebenuwa, Yu Wang, Mahtab Niyyati, Sebastian J. Padayatty, Brian Head, Kenneth J. Wilkins, Stacey Chung, Varsha Thakur, Lynn M. Ulatowski et al. · 2019 · JCI Insight
  98. HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C
    Vito Fiore, Giuseppe De Matteis, Roberto Ranieri, Laura Saderi, Emanuele Pontali, Alberto Augusto Muredda, Anna Maria Ialungo, Rosa Caruso, Giordano Madeddu, Giovanni Sotgiu et al. · 2020 · International Journal of Drug Policy
  99. Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population‐based study
    Elisa Pose, Guillem Pera, Pere Torán‐Monserrat, Jordi Gratacós‐Ginès, Emma Avitabile, Carmen Expósito, Alba Díaz, Isabel Graupera, Ana Belén Rubio, Pere Ginès et al. · 2021 · Liver International
  100. Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan
    Tsung‐Hui Hu, Wei‐Wen Su, Chi‐Chieh Yang, Chih‐Chao Yang, W-Hsien Kuo, Yang‐Yuan Chen, Yung‐Hsiang Yeh, Shiou-Shiang Chen, Yu-Yu Tsao, Kwei‐Ming Chen et al. · 2021 · American Journal of Kidney Diseases